Management of hereditary angioedema: 2010 Canadian approach
暂无分享,去创建一个
[1] P. Keith,et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.
[2] H. Farkas. Management of upper airway edema caused by hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.
[3] M. Gompels,et al. HAE international home therapy consensus document , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.
[4] K. Bork. Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.
[5] P. Pundir,et al. Comparison of the inhibitory effects of resveratrol and tranilast on IgE, 48/80 and substance P dependent-mast cell activation , 2010, Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology.
[6] O. Fain. [Acquired angioedema]. , 2010, La Revue de medecine interne.
[7] William H. Yang,et al. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[8] K. Khair,et al. C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option , 2006, Clinical and experimental immunology.
[9] M. Cicardi,et al. Angioedema without urticaria: a large clinical survey , 2006, Canadian Medical Association Journal.
[10] William H. Yang,et al. Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2004, The Journal of allergy and clinical immunology.
[11] M. Cicardi,et al. C1 inhibitor concentrate therapy in 473 patients with hereditary and acquired angioedema , 2004 .
[12] William H. Yang,et al. Management of hereditary angioedema: a Canadian approach. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[13] M. Cicardi,et al. How do we treat patients with hereditary angioedema. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[14] B. Ritchie. Tissue archives to track blood borne pathogens in people receiving blood products. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[15] K. Binkley,et al. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. , 2000, The Journal of allergy and clinical immunology.
[16] K. Bork,et al. Hereditary angioedema with normal C1-inhibitor activity in women , 2000, The Lancet.
[17] M. Cicardi,et al. Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.
[18] H. Strawczynski,et al. Delivery of care to hemophilic children: home care versus hospitalization. , 1973, Pediatrics.
[19] F. Rosen,et al. Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. , 1971, The Journal of clinical investigation.
[20] R. R. Evans,et al. A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.